CDH1 and neoplasm: As a key adhesive molecule in the prevention of tumor progression, E-cadherin undergoes a series of negative regulations in multiple tumors, including mutations [2, 3], epigenetic silencing [4, 5], transcriptional regulation [6], and endocytosis [7].